Tech Company Financing Transactions
Vasculox Funding Round
On 8/10/2015, Vasculox raised $8.1 million in financing from private investors.
Transaction Overview
Company Name
Announced On
8/10/2015
Transaction Type
Venture Equity
Amount
$8,134,451
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Ave. 304
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Website
Email Address
Overview
Vasculox, Inc., is a biotechnology company focused on novel therapies for disorders driven by CD47 signaling pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Donovan
Chief Scientific Officer
Robert Karr
VP - Bus. Development
James Stutz
VP - Product Management
Bradley Keller
VP - R & D
Pamela Manning
Browse more venture capital transactions:
Prev: 8/10/2015: LabStyle Innovations venture capital transaction
Next: 8/11/2015: Generico venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs